In this issue:
Vedolizumab superior to infliximab in biologic-naïve UC
Cost-effectiveness of laparoscopic vs. open gastrectomy for gastric cancer
SER-109 (microbiome therapeutic) for recurrent C. difficile infection
Second-line levofloxacin- vs. bismuth-based quad therapy for H. pylori eradication
Antimicrobial resistance in H. pylori isolates from clinical trial participants
Yoga for IBS
Head box to reduce aerosol exposure during upper GI endoscopy
More upper but not lower GI bleeding with warfarin vs. DOACs
Induction risankizumab for CD
AI-assisted colonoscopy for colorectal cancer screening
Please login below to download this issue (PDF)